Treatment of vitiligo in large areas with hair

In the case of vitiligo that affects areas where hair grows, such as the legs, arms and trunk, the treatment that is recommended combined use of phototherapy and photosensitising oral and topical products.

The Fenadul Line has photosensitising oral and topical products that provide the depigmented skin with the essential amino acid L-Phenylalanine.

Recommended treatment

Recommended treatment, three times a week::

  • Take Fenadul Capsules Capsules in one single dose (6 capsules per 60 kilos of weight).
  • 15 minutes after taking the capsules, apply Fenadul Gel to the area/s requiring re-pigmentation.
  • 30 minutes after applying the Gel, use the narrow UVB lampfollowing the instructions.

The application times are measured in seconds and the initial exposure time is always 29 seconds, because the skin is de-pigmented and corresponds to Photo-type I or II

The treatment should last between 6 and 24 months to obtain results.

Success stories

Actual photographs of patients treated with Fenadul, Meladul and phototherapy. Patients aged from 8 to 45 subject to treatment for 2 to 4 months.

Bibliografía

Vitíligo, actualidad terapéutica

Dr. Agustín Alomar; Joan Dalmau Arias, Esther Roé Crespo. Departamento de Dermatología del Hospital de la Santa Creu i Sant Pau. Barcelona.

Depresión en adultos con vitiligo que asisten a una consulta dermatológica

María Gabriela Blanco | Publicado: 27/03/2010 | Psicología, Dermatología y Venereología, Psiquiatría

Vitíligo

Dres. J.L. Rodríguez Peralto, J. Salamanca y B. Rosales Trujillo

Factores psicobiológicos en vitiligo infantil: Posible rol en su génesis e impacto en la calidad de vida

Rodrigo Schwartz, Juan Enrique Sepúlveda, Teresa Quintana

Nuevas opciones en el tratamiento del vitíligo

F. J. MIQUEL MIQUEL Y A. ALIAGA BONICHE Servicio de Dermatología. Hospital de la Ribera. Alzira (Valencia). Servicio de Dermatología. Hospital General Universitario. Valencia

Actualización en Vitíligo

IntraMed – Artículos – Dres. Alain Taieb y Mauro Picardo. The New England Journal of Medicine, 2009; 130:160-169.

Abedul

Productos farmacéuticos

  • Polígono la Estrella, C/ Berroa nave 16
    31192, Tajonar – Navarra
  • 00 34 948 806 051
  • admin@abedulfarma.com
Pago seguro
0
    0
    Tu pedido
    Your cart is emptyReturn to Shop